机译:Population pharmacokinetics of tanezumab following intravenous or subcutaneous administration to patients with osteoarthritis or chronic low back pain
Pharmacometrics,Pfizer R&D Japan;
Clinical Pharmacology, Global Product Development,Pfizer;
Pharmacometrics,Pfizer R&D Ltd.;
chronic low back pain; nerve growth factor; osteoarthritis; population pharmacokinetics; tanezumab;